Cytek Biosciences Inc.

NASDAQ: CTKB · Real-Time Price · USD
4.02
-0.06 (-1.47%)
At close: Aug 15, 2025, 1:23 PM

Cytek Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
98.72M 167.3M 296.6M 364.62M
Short-Term Investments
179.15M 95.11M 44.55M n/a
Long-Term Investments
n/a 1.6M 1.6M n/a
Other Long-Term Assets
4.76M 1.78M 1.36M 1.67M
Receivables
60.59M 56.12M 48.86M 29.76M
Inventory
43.89M 60.88M 48.15M 32.17M
Other Current Assets
1.97M 2.56M 10.79M 708K
Total Current Assets
396.45M 392.06M 454.02M 432.05M
Property-Plant & Equipment
28.13M 29.26M 27.57M 5.85M
Goodwill & Intangibles
36.79M 39.27M 14.47M 14.88M
Total Long-Term Assets
103.05M 102.4M 65.46M 31.65M
Total Assets
499.5M 494.46M 519.48M 463.7M
Account Payables
5.53M 3.03M 4.8M 3.03M
Deferred Revenue
25.49M 22.7M 12.99M 7.08M
Short-Term Debt
4.66M 565K 9.69M n/a
Other Current Liabilities
10.24M 21.2M 21.1M 11.47M
Total Current Liabilities
67.66M 56.23M 49.04M 32.16M
Long-Term Debt
1.05M 1.65M 2.27M n/a
Other Long-Term Liabilities
27.5M 18.91M 17.18M 14.95M
Total Long-Term Liabilities
36.1M 45.17M 44.89M 24.74M
Total Liabilities
103.76M 101.39M 93.93M 56.9M
Total Debt
17.02M 14.14M 18.09M n/a
Common Stock
129K 131K 135K 126K
Retained Earnings
-35.2M -29.18M -17.03M -18.19M
Comprehensive Income
16K -1.27M -697K 897K
Shareholders Equity
395.74M 393.06M 425.3M 406.46M
Total Investments
179.15M 96.71M 44.55M n/a